Lucké 1 has determined the survival time in 100 fatal cases of lower-nephron nephrosis. Ninety-five per cent of the patients succumbed within fourteen days, 86 per cent within ten days ...

Table 1. Diabetic Nephropathy Stages: Cutoff Values of Urine Albumin for Diagnosis and Main Clinical Characteristics Stages Albuminuria cutoff values (ref. 14) Clinical characteristics (ref. no.) ...

Chronic kidney disease (CKD) is defined as a progressive loss of renal function that lasts for more than 3 months, and is classified according to the degree of kidney damage – measured by the le ...

Diabetic nephropathy is a progressive kidney disease associated with diabetes mellitus – type 1 and type 2 – affecting kidney glomeruli, arterioles, tubules and the interstitium. Clinical ...

Obesity is a widespread health issue influenced by genetic and lifestyle factors. This article explores its definition, ...

IgA nephropathy (also known as IgAN or Berger’s disease) is an autoimmune disorder that occurs when the immune system mistakenly attacks glomeruli—tiny blood vessels in the kidneys that filter ...

Avoiding certain foods when you have kidney disease can help slow disease progression and make you feel healthier, longer. It's especially important to limit those high in the minerals that your ...

Immunoglobulin A nephropathy (also known as IgA nephropathy or Berger's disease) is a condition that causes IgA antibodies to accumulate in the kidneys—leading to damage that affects their blood ...

Chronic kidney disease isn't usually diagnosed until your kidney function drops below a certain level of function. In the early stages of chronic kidney disease, you may not have any symptoms at all.

New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease.

PIONEER study expands the investigation of atacicept into a broad definition of IgA nephropathy and into multiple autoimmune ...

Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...